Search Results - "Nakamoto, Meagan"
-
1
Nonspecific Binding of RNA to PARP1 and PARP2 Does Not Lead to Catalytic Activation
Published in Biochemistry (Easton) (24-12-2019)“…Poly(ADP-ribose) polymerases 1 and 2 (PARP1 and PARP2, respectively), upon binding damaged DNA, become activated to add long chains of poly(ADP-ribose) (PAR)…”
Get full text
Journal Article -
2
hnRNPK recognition of the B motif of Xist and other biological RNAs
Published in Nucleic acids research (18-09-2020)“…Heterogeneous nuclear ribonuclear protein K (hnRNPK) is an abundant RNA-binding protein crucial for a wide variety of biological processes. While its binding…”
Get full text
Journal Article -
3
Spen links RNA-mediated endogenous retrovirus silencing and X chromosome inactivation
Published in eLife (07-05-2020)“…The lncRNA mediates X chromosome inactivation (XCI). Here we show that Spen, an -binding repressor protein essential for XCI , binds to ancient retroviral RNA,…”
Get full text
Journal Article -
4
Structural and Functional Effects of Cu Metalloprotein-Driven Silver Nanoparticle Dissolution
Published in Environmental science & technology (05-06-2012)“…Interactions of a model Cu-metalloprotein, azurin, with 10–100 nm silver nanoparticles (NPs) were examined to elucidate the role of oxidative dissolution and…”
Get full text
Journal Article -
5
Non-specific binding of RNA to PARP1 and PARP2 does not lead to catalytic activation
Published in Biochemistry (Easton) (16-12-2019)“…Poly-(ADP-ribose) polymerase 1 and 2 (PARP1 and PARP2), upon binding damaged DNA, become activated to add long chains of poly-(ADP-ribose) (PAR) to themselves…”
Get full text
Journal Article -
6
Molecular Recognition Underlying X Chromosome Inactivation: Interactions Between hnRnpk and Spen with Different Regions of Xist
Published 01-01-2020“…X chromosome inactivation (XCI) is a developmental process in which mammalian females transcriptionally silence one of their two X chromosomes to achieve gene…”
Get full text
Dissertation -
7
Abstract 2780: Unique pharmacodynamic properties conferred by differential binding to BTK, pirtobrutinib vs covalent inhibitors
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Covalent Bruton tyrosine kinase inhibitors (cBTKi) have transformed the treatment of B cell malignancies. Despite the efficacy of cBTKi, treatment…”
Get full text
Journal Article